Category: Latest News
-

Laser Photonics Completes Laser Shield Anti-Drone Prototype, Advancing LSAD Demonstration Phase (LASE)
The company has moved its Laser Shield Anti-Drone platform into demonstrations with U.S. and international defense stakeholders, marking a key step toward potential procurement opportunities. Key Investor Takeaways Why LASE Stock Is In Focus Laser Photonics announced the completion of final assembly for its Laser Shield Anti-Drone (LSAD) prototype, a milestone that shifts the program…
-

Wall Street Set for Rebound as Investors Hunt for Bargains After Sell-Off: Dow Jones, S&P, Nasdaq, Futures
U.S. stock futures pointed to a stronger open on Thursday, indicating that equities could recover some of the heavy losses recorded in the previous session. Investors appear to be stepping back into the market after Wednesday’s sharp decline, which pushed both the Nasdaq and the S&P 500 to their lowest closing levels in a month.…
-

U.S. Jobless Claims Climb Above Expectations in Latest Labor Market Reading
The latest U.S. initial jobless claims report delivered an unexpected increase, pointing to potential softening in labor market conditions. According to the newest figures, 229,000 people filed for unemployment benefits for the first time during the past week, exceeding economists’ expectations. Analysts had forecast that initial claims would fall to 220,000. Instead, the number came…
-

U.S. Producer Prices Hold Firm as PPI Comes in Above Expectations
The latest U.S. Producer Price Index (PPI) report showed no change from the previous month, surprising economists who had anticipated a slowdown in producer price growth. The data offers a fresh insight into inflation trends at the wholesale level and could influence expectations for future monetary policy decisions. The annual PPI reading remained at 1.1%,…
-

Honeywell Technologies Unveils Three-Year Growth Targets Ahead of Aerospace Separation (HON)
Honeywell (NASDAQ:HON) outlined new long-term financial objectives for Honeywell Technologies during an investor day held in New York on June 11, as the company prepares for the planned spin-off of Honeywell Aerospace on June 29. The event provided investors with a clearer view of the strategy and growth outlook for the automation-focused business that will…
-

Intel Shares Surge After BofA Upgrades Stock to Buy on CPU and Foundry Growth Prospects (INTC)
Intel (NASDAQ:INTC) shares rose about 5% in premarket trading after Bank of America upgraded the stock twice, moving its rating from Underperform to Buy and increasing its price target to $135 from $96. The investment bank cited improving visibility around Intel’s server processor business and expanding opportunities within its external foundry operations as key reasons…
-

Driven Brands Tops Earnings Forecasts but Revenue Falls Short as Outlook Remains Unchanged (DRVN)
Driven Brands Holdings Inc. (NASDAQ:DRVN) reported first-quarter results on Thursday that exceeded profit expectations but came in slightly below revenue forecasts, while management reaffirmed its full-year guidance. Shares of the automotive services group were little changed in premarket trading, edging up 0.07% following the announcement. Earnings Beat Despite Revenue Miss The company delivered adjusted earnings…
-

McGraw Hill Shares Slide Despite Earnings and Revenue Beat (MH)
McGraw Hill Inc. (NYSE:MH) reported fourth-quarter fiscal 2026 results that surpassed Wall Street expectations, but the strong performance failed to prevent a sharp decline in its share price as investors weighed broader concerns surrounding the education company’s outlook. The education technology and learning solutions provider saw its shares fall 12.50% in premarket trading on Thursday…
-

Rubrik Unveils Control and Recovery Tools for Anthropic’s Claude AI Agents (RBRK)
Rubrik (NYSE:RBRK) has introduced Rubrik Agent Cloud for Anthropic’s (NASDAQ:ANTP) Claude Code and Claude Cowork, providing organizations with new capabilities to deploy, monitor and manage AI-powered agents while maintaining greater operational control. The launch includes tools designed to track agent activity, recover from unintended actions and strengthen resilience as enterprises increasingly adopt autonomous AI systems.…
-

Johnson & Johnson Reports Strong Late-Stage Results for Rare Blood Disorder Therapy (JNJ)
Johnson & Johnson (NYSE:JNJ) has announced positive findings from its Phase 2/3 ENERGY clinical trial, with IMAAVY (nipocalimab-aahu) demonstrating statistically significant improvements in hemoglobin levels among patients with warm autoimmune hemolytic anemia compared with placebo. The results provide further support for the therapy as the company seeks regulatory approval for a condition that currently has…